Business Insights and Analytics

Our Insight team applies rigorous analysis and expert interpretation in order to provide strategic recommendations

Read more

Strategic and Scientific Consulting

Our Consulting team help solve complex scientific and commercial challenges and drive strategy throughout the product lifecycle

Read more

Scientific and Creative Communications

Our Communications team care passionately about the science and making evidence matter across the entire healthcare spectrum

Read more

Business Insights and Analytics

Plus icon

Our Insight team applies rigorous analysis and expert interpretation in order to provide strategic recommendations

Read more

Strategic and Scientific Consulting

Plus icon

Our Consulting team help solve complex scientific and commercial challenges and drive strategy throughout the product lifecycle

Read more

Scientific and Creative Communications

Plus icon

Our Communications team care passionately about the science and making evidence matter across the entire healthcare spectrum

Read more

Why we do what we do

The healthcare industry is going through fundamental change and in this uncertainty our clients need to convert great science into winning strategy

Our clients tell us they need our support in making the right strategic decisions that ensure their products fulfill their potential and ultimately improve people’s lives

We love working at the cutting edge, helping to tackle our clients’ newest and most complex problems

Teams of experts

We are expert navigators helping guide our clients to more successful outcomes

With a global perspective

We work with 24 of the top 25 pharmaceutical companies as well as 100s of biotechs globally from our offices in the US and Europe

Solving unique problems

Whether we are supporting you on your journey, or delivering specialist expertise, we are helping you make important choices

Share our fresh thinking >

Next Wave AntiCancer Therapies Part 1
Next Wave AntiCancer Therapies Part 1
“In 1890, the Russian playwright and physician Anton Chekov wrote a letter in which he alluded to a centuries-old observation that infections seemed to slow the growth of malignant tumors.
Pharma perspective: Does the patient journey inform better strategy and enhance patient outcomes?
Pharma perspective: Does the patient journey inform better strategy and enhance patient outcomes?
Q&A with Pharma Progress 2021 panellist: Daniel De Schryver, Patient Engagement & Advocacy Lead, Europe, Middle-East and Africa, Janssen1.
Anticancer Cellular Immunotherapies: Optimizing the Path from Bench to FDA Approval
Anticancer Cellular Immunotherapies: Optimizing the Path from Bench to FDA Approval
A striking number of anticancer cellular immunotherapies, also commonly referred to as adoptive cellular therapies (ACT), are in various stages of development, either as monotherapies or in combination with other treatments.
What does patient centricity mean to you?  Q&A with Pharma Progress speaker Ceinwen Giles
What does patient centricity mean to you? Q&A with Pharma Progress speaker Ceinwen Giles
1. What does patient centricity mean to you?Putting the patient “at the centre” of everything that you do sounds relatively easy but, patient centricity is about firmly putting this thought into direct action.

Let’s work together

The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today.